Global Finance

Rich Man, Poor Man: A Clash Foretold

In November, a Chinese billionaire – one not yet clipped and cuffed at the order of President Xi Ping – acquired Amedeo Modigliani’s Reclining...
Social Supermarket BCorp

Social Supermarket’s grand branding idea for social impact

THE UK's largest marketplace for social impact products has announced the launch of a Branded Merchandise offering for corporates. The B Corp-certified organisation’s business model...
Companies House logo

Mind your language! Rude company names are out

A FREEDOM of information (FOI) request found that 56,640 business names were rejected by Companies House between January 2019 and April 2022. Nearly half (25,400)...
Grain elevator

Energy exchange group acquires Nasdaq future and options business

ENERGY exchange EEX Group has announced an agreement with US-based Nasdaq Futures (NFX) to buy its futures and options exchange business. The German-based European Energy...

Ray Tomlinson – the alpha email

WHEN Ray Tomlinson inadvertently invented the email, he had no idea his coding and revolutionary use of the ‘@’ sign would change the world...
British Airways

Quarter of BA jobs going: 12,000 staff members face the axe

BRITISH Airways says it will be forced to make up to 12,000 staff redundant because of the global collapse of air travel. CEO Alex Cruz...
Salmon

Scottish Salmon – What’s the catch?

It’s one of the biggest businesses in Scotland, but ask ten different experts about the state of the salmon industry and you’ll get ten...
Fake supercar factory

Switcheroo ‘supercars’ draw heat in Brazilian swoop on chop-shop

By Hal Williams YOU only get one chance to make a first impression, they say, and nothing makes a statement like pulling up to your...
Factoring

When debt can be an asset…

FACTORING could be simplified and summed-up as buying debt. Along with wider bank support and government initiatives, it is seen as a route to liquidity...
Oxycontin tablets

Court proceedings mount against pharma firms behind OxyContin

JOHNSON & Johnson, Purdue Pharma and Israel-based firm Teva Pharmaceuticals are under increased legal pressure over their roles in the US’s opiate crisis. (Click here...